R&G Pharma
30133347.203.35% ( +1.53 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: R&G Pharma(301333) the Revenue is 218.09 M (+26.18%);the EBIT is 26.18 M (+12.06%);the EPS is 0.24 (-11.11%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.22B26.18%
----
----
EBIT
0.03B12.06%
----
----
EPS
0.2411.11%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf